Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Piroxicam and carboplatin in canine oral non-tonsillar squamous cell carcinoma
Squamous cell carcinomas of the oral mucosa are known to be very aggressive and often very frustrating in their therapy. Does this combination of carboplatin and piroxicam coming from human medicine offer better therapeutic results than the current therapies? At least the preliminary results seems to be promising!

Results of the treatment with a combination of carboplatin and piroxicam in seven dogs with advanced non-tonsillar oral squamous cell carcinoma (SCC) were retrospectively analysed.

This multi-agent protocol was well tolerated by all dogs and resulted in a complete regression of the tumour without additional surgery in four of seven patients.
Additional surgery was necessary to remove a metastatic lymph node in one dog and residual tumour in a second dog, which achieved a partial response following medical therapy.

Median follow-up for all the dogs was 534 days, while the time-to-recurrence, time-to-progression and overall survival for this group of patients have not yet been reached.

Our study, although limited in number of animals, suggests that this multiagent approach is a useful treatment option for oral non-tonsillar SCC in dogs and warrants wider application.



Source: de Vos, J. P., Burm, A. G. D., Focker, A. P., Boschloo, H., Karsijns, M. & van der Waal, I. (2005): Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma. In: Veterinary and Comparative Oncology 3 (1), 16-24.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Prevalence of impinged spinous processes in asymptomatic dogsmembers
One hundred and ninety lateral thoracic radiographs of asymptomatic dogs radiographed for reasons other than spinal pain, were retrospectively reviewed by two board-certified radiologists. Images were assessed for impinged spinous processes and graded for narrowing, sclerosis or remodelling of the spinous processes.
How is the prevalence of impinged spinous processes in this group of dogs?

  • Intraocular pressure curve protocol for use in dogsmembers
  • Atopic dermatitis and the intestinal microbiota in dogs and menmembers
  • Bacterial contamination and DNA quantification in stored blood units members
  • Atypical chorioretinal coloboma in a Golden Retrievermembers
  • Oral direct factor Xa inhibitor anticoagulant in healthy adult horsesmembers
  • Use of three human cervical fusion implants in the canine cervical vertebral columnmembers
  • Radiotherapy for canine adrenocortical tumours with vascular invasionmembers
  • Intrahepatic portocaval shunt in dogs - diagnosis and therapymembers
  • Renal Abnormalities in Dogs with Coccidioidomycosismembers
  • Novel retinopathy in related Gordon settersmembers
  • Tolerability of a rapid-escalation vinblastine-prednisolone protocol in canine mast cell tumoursmembers
  • Retrospective Study of Feline Exocrine Pancreatic Insufficiencymembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved